Markey Cancer Center/University of Kentucky

Lexington, Kentucky 40536

1 studies enrolling now · 12 studies all time

What they study most

Adult B Cell ALL, B-cell Lymphoma, B-cell Malignancy, Brain Cancer, Brain Tumor, Cancer, Carcinoma Transitional Cell, Carcinoma in Situ, GBM, Glioblastoma, Glioblastoma Multiforme, Glioma

Studies at this site

• Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies — Recruiting now
• A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) — Stopped early
• A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON) — Stopped early
• Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer — Completed
• Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma — Completed
• Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma — Completed
• Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors — Completed
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• Biobehavioral Intervention in Gynecologic Oncology Patients — Completed
• A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer — Completed
• A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies — Completed
• Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer — Completed